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Introduction
The V3 region of the HIV-1 envelope complex is known
to play a pivotal role in directing the choice between
the chemokine receptors CCR5 and CXCR4 for use as
coreceptors, but the underlying structural mechanism
is as yet unknown (reviewed in Hartley et al. [2005]).
Sharon et al. have proposed a model in which V3 drives
coreceptor choice by adopting structures that mimic
b-hairpin loops (40’s loops) from chemokines selective
for either CCR5 or CXCR4 (Sharon et al., 2003). The
model is centered on evidence that structures adopted
by V3-derived peptides in complex with V3-directed
neutralizing antibodies show significant structural
homology with 40’s loops from (1) CCR5 binding chemo-
kines in the case of the proposed ‘‘CCR5-tropic confor-
mation’’ (1NIZ [Sharon et al., 2003]), and (2) the CXCR4
binding chemokine SDF-1 (CXCL12) in the case of the
proposed ‘‘CXCR4-tropic conformation’’ (1QNZ [Tugar-
inov et al., 2000]).
While the structural analogy model has attracted in-
terest because of its relevance to the development of
vaccine strategies based on HIV-1 V3 (Rosen et al.,
2005; Zolla-Pazner, 2004), a number of theoretical ob-
jections have been raised (Hartley et al., 2005; Lusso,
2003). Here we present new data concerning the extent
of structural similarity between antibody-complexed V3
structures and 40’s loop regions from all of the chemo-
kines for which structural data is available. Our results
challenge the Sharon et al. (2003) model by showing
that the degree of similarity between the structures
of V3 and those of b-hairpins from HIV-1 coreceptor-
selective chemokines is too low to be of biological
significance.
Results
We searched the Protein Data Bank (PDB) for structures
of human chemokines, finding 23 from the total of 42
*Correspondence: oliver.hartley@medecine.unige.chrecognized family members (for procedures see the
Supplemental Data available with this article online),
and extracted backbone coordinates and sequences
corresponding to 40’s loops (Table S1). MOLMOL align-
ment of the V3MN/447-52D backbone coordinates (1NIZ)
with the chemokine 40’s loops showed that at the level
of conformation, 40’s loops from CCR5 binding chemo-
kines are no more similar to V3MN/447-52D than 40’s
loops from chemokines that do not bind CCR5 (Figures
1A and 1B). The average rmsd values across the group
of chemokine 40’s loops lay in the range 2.79–3.19 A˚,
with average rmsd values for 40’s loops from chemo-
kines that bind CCR5 ranked 4th, 8th, 9th, and 14th
(Table S3). Three 40’s loops from chemokines that do
not bind to CCR5 (CX3CL1, CCL17, and CCL20) gave
lower average rmsd values with respect to V3MN/447-
52D than the highest ranked 40’s loop from a CCR5
binding chemokine (CCL8). A further seven 40’s loops
from chemokines that do not bind CCR5 (CXCL7,
CCL7, CCL26, CCL23, CCL2, CCL15, and XCL1) have
lower rmsd values than the lowest ranked 40’s loop
from a CCR5 binding chemokine (CCL5). Broadly similar
results (Figures 1C and 1D; Table S4) were obtained for
analogous alignments using the crystal structure coor-
dinates for V3MN/447-52D (1Q1J [Stanfield et al.,
2004]), as well as the coordinates of another V3 peptide
from a different CXCR4-tropic envelope (V3IIIB) in com-
plex with the same antibody (1U6U [Rosen et al.,
2005]; Table S5). This broad similarity is not unexpected
given the overall similarity between the 447-52D-com-
plexed peptide structures (Rosen et al., 2005; Stanfield
et al., 2004).
As previously noted (Sharon et al., 2003), the se-
quence motif best described by V3MN contact residues
in the V3MN/447-52D complex, [I/L/V]-[Y/F/H]-[I/L/V]-X-
X-X-[R/K], is not present in the 40’s loops of the chemo-
kines that bind CCR5, nor is it present in the 40’s loops of
any of the other chemokines (Table S1). The model pro-
posed by Sharon et al. featured three alternative se-
quence motifs to describe structural similarity between
the 40’s loops of CCR5 binding chemokines and V3MN/
447-52D: (i) [I/L/V]-[Y/F/H]-[I/L/V]-X-X-[R/K], (ii) [I/L/V]-
[Y/F/H]-X-X-X-[R/K], and (iii) [I/L/V]-[Y/F/H]-X-X-X-X-X-
[R/K] (Sharon et al., 2003). Motif (i), while present in
two of the 40’s loops from CCR5 binding chemokines
(CCL3 and CCL5), is absent in two others (CCL4 and
CCL8). Additionally, this motif is present in the 40’s
loops of three chemokines that do not bind to CCR5
(CCL15, CCL23, and XCL1). While motifs (ii) and (iii) are
both present in the 40’s loops of all four CCR5 binding
chemokines, they are additionally present in the 40’s
loops of seven (CCL1, CCL15, CCL20, CCL23, CCL24,
CCL26, and XCL1) and nine (CCL1, CCL2, CCL7,
CCL11, CCL15, CCL17, CCL23, CCL24, and CCL26)
chemokines that do not bind CCR5, respectively (Table
S1). Notably, among the 40’s loops from chemokines
that do not bind CCR5 and which contain the sequence
motifs, there are several which have backbone confor-
mations at least as similar to V3MN/447-52D as those
of the 40’s loops from the CCR5 binding chemokines.
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V3MN structures are shown in red; chemokine 40’s loop structures are shown in black.
(A) V3MN/447-52D structure from Sharon et al. (2003) (1NIZ) superimposed with CCR5 binding chemokines CCL3, CCL4, CCL5, and CCL8.
(B) 1NIZ 14-mer superimposed with chemokines that do not bind CCR5: CCL17, CCL20, and CX3CL1.
(C) V3MN/447-52D structure from Stanfield et al. (2004) (1Q1J) superimposed with CCR5 binding chemokines CCL3, CCL4, CCL5, and CCL8.
(D) 1Q1J 10-mer superimposed with chemokines that do not bind CCR5: CCL17, CCL20, and CX3CL1.Together, our analyses based on conformation and
sequence indicate that the V3MN/447-52D structure is
no more similar to that of the 40’s loops from chemo-
kines that bind to CCR5 than it is to the 40’s loops of
chemokines in general. With respect to nonchemokine
b-hairpin structures, when we used the V3MN/447-52D
coordinates (1NIZ) to probe a structural database using
SPASM, we did not obtain any chemokine hits for che-
mokine 40’s loops, even at the lowest level of stringency
used (7823 hits; Table S7). The only chemokine-related
structures isolated at this level of stringency were not
40’s loop structures, nor were they from CCR5 binding
chemokines. Additionally, 321 of the 7823 hits featured
one or more of the sequence motifs (i), (ii), and (iii)
from the Sharon et al. (2003) model. Hence we conclude
that the relatively low level of structural similarity be-tween V3MN/447-52D and 40’s loops from the chemo-
kine family is most likely a consequence of the overall
similarity between b-hairpin structures in general.
We next used MOLMOL alignment to analyze the
extent of structural similarity between V3IIIB/0.5b and
chemokine 40’s loops. V3IIIB/0.5b is indeed significantly
more similar at the level of conformation to the 40’s loop
of SDF-1 (CXCL12) than it is to the 40’s loops of the other
chemokines (Table S6). This is certainly due in part to the
backbone hydrogen bonding shift described by Rosen
et al. (2005), but we note that another chemokine 40’s
loop, that of CXCL10, also features a similar shift (Fig-
ure S1). The [A/I/L/V]-[H/R/K]-[A/I/L/V] consensus se-
quence motif put forward by Sharon et al. (2003) is not
present in the N-terminal b strands of any of the chemo-
kine 40’s loops except for that of CXCL12. Given thisTable 1. Summary of Theoretical and Structural Evidence against the Structural Analogy Model
V3MN/447-52D as ‘‘R5 Conformation’’
The V3MN peptide comes from an X4 HIV strain.
Mab 447-52D binds to and neutralizes both X4 and R5 HIV strains (Gorny et al., 2002).
V3MN/447-52D does not show remarkable structural similarity to regions of CCR5 binding chemokines, either at conformation or
sequence level.
Many nonchemokine loops more similar in conformation to V3MN/447-52D than to those from chemokines.
V3IIIB/0.5b as ‘‘X4 Conformation’’
Mab 0.5b is a strain specific neutralizing antibody (Matsushita et al., 1988). As such it is of limited relevance to a structural analogy
model that addresses conformations potentially adopted by a broad range of viral strains.
V3 peptides bound to other strain-specific neutralizing antibodies adopt different conformations to V3IIIB/0.5b (Stanfield et al., 2003).
Although V3IIIB/0.5b is more similar in conformation to region in SDF-1 than to the same region in other chemokines, many nonchemokine
loops are yet more similar in conformation, including those that feature proposed sequence motif.
General
Chemokine 40’s loop regions not generally responsible for conferring receptor selectivity (Clark-Lewis et al., 1995; Wells et al., 1996).
Proposed sequence motifs are located in chemokine regions that are solvent inaccessible in all available structures (Figure S2).
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ilarity between the 40’s loop of CXCL12 and V3IIIB/0.5b
likely to be of biological significance? To address this
question we performed a SPASM search based on the
coordinates of V3IIIB/0.5b. Only at the lowest stringency
used (search yielded a total of 1199 hits; Table S7) did
the query identify any chemokine-derived hits. These
were the 40’s loops from CXCL12 and CXCL10 (1A15
and 1O7Z), ranked 1045th and 1083rd, respectively. Of
the 1044 b-hairpin loop structures with conformations
more similar to V3IIIB/0.5b than the 40’s loop of
CXCL12, 51 also had N-terminal b strands containing
the [A/I/L/V]-[H/R/K]-[A/I/L/V] sequence motif. Hence al-
though V3IIIB/0.5b is significantly more similar in struc-
ture to the 40’s loop of CXCL12 than it is to the 40’s
loop b-hairpins from other chemokines, the extent of
this similarity is unremarkable in a wider context of
b-hairpin loops in general. Additionally, we note that
since Mab 0.5b, unlike 447-52D, is a strain-specific neu-
tralizing antibody (Matsushita et al., 1988), it is of ques-
tionable relevance to a structural analogy model that
addresses conformations potentially adopted by a
broad range of viral strains.
Conclusions
The evidence presented here (Table 1) suggests that V3-
driven coreceptor choice cannot be explained in terms
of structural analogy with regions of chemokines that
bind to HIV-1 coreceptors. How then, might V3 influence
which coreceptor is used? While our findings do not ex-
clude a role for conformational changes, available data
concerning (1) overall similarity of structures adopted
by V3 peptides in complex with neutralizing antibodies
(Rosen et al., 2005; Stanfield et al., 2003), and (2) the abil-
ity of certain V3-specific neutralizing antibodies, like
447-52D, to inactivate both R5 and X4 HIV-1 strains,
suggest that R5 and X4 strains might present a single
predominant V3 conformation, and that coreceptor
choice is driven by changes at the sequence level in
the context of this conformation. In this light it is inter-
esting to note that corresponding residues from the V3
region of R5-tropic HIVJR-FL in the first published crystal
structure of a V3-containing HIV gp120 core (Huang
et al., 2005) adopt a similar conformation to the V3-de-
rived peptides in complex with 447-52D (Table S8), sug-
gesting that (1) the 447-52D-complexed peptide struc-
tures are likely to be biologically relevant, and (2) V3
regions from both R5- and X4-tropic strains might adopt
a single similar predominant conformation. Additional
structural information concerning, for example (1) anti-
body-complexed V3 peptides derived from R5-tropic
strains and (2) structures adopted by V3 regions in the
context of the intact envelope complex, will be neces-
sary to provide an ultimate answer to this question.
Supplemental Data
Supplemental Data including one figure and eight tables are available
at http://www.structure.org/cgi/content/full/14/4/645/DC1/.
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